TerminatedPhase 1NCT00145886
rhPTH Therapy for Low Turnover Bone Fragility
Studying Albers-Schönberg osteopetrosis
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- University of Chicago
- Principal Investigator
- Tamara Vokes, MD, MDUniversity of Chicago
- Intervention
- rhPTH(drug)
- Enrollment
- 2 enrolled
- Eligibility
- 20 years · All sexes
- Timeline
- 2003 – 2011
Study locations (1)
- University of Chicago, Chicago, Illinois, United States
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT00145886 on ClinicalTrials.gov